Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfer factor.

C H Kirkpatrick

    CRC Critical Reviews in Clinical Laboratory Sciences
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Researchers are identifying the molecules responsible for passive immune transfer using transfer factor (TF). Clinical trials are evaluating TF for treating infections, cancers, and autoimmune diseases, with ongoing reviews of its components and efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

    Clinical and experimental immunology·2014
    Same author

    Chronic mucocutaneous candidiasis.

    The Pediatric infectious disease journal·2001
    Same author

    Transfer factors: identification of conserved sequences in transfer factor molecules.

    Molecular medicine (Cambridge, Mass.)·2000
    Same author

    Eleventh International Congress on Transfer Factors: March 1-4, 1999, Monterrey, Nuevo Leon, Mexico.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
    Same author

    Recognition of the immunocompromised patient.

    Chest surgery clinics of North America·1999
    Same author

    A man with multiple infections with unusual organisms.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1999
    Same journal

    Problems associated with clinical chemistry quality control materials.

    CRC critical reviews in clinical laboratory sciences·1980
    Same journal

    Binding of bilirubin to albumin.

    CRC critical reviews in clinical laboratory sciences·1980
    Same journal

    Soluble immune complexes in human disease.

    CRC critical reviews in clinical laboratory sciences·1980
    Same journal

    Structural, functional, and clinical aspects of gamma-glutamyltransferase.

    CRC critical reviews in clinical laboratory sciences·1980
    Same journal

    Screening tests for cell-mediated immunodeficiency diseases.

    CRC critical reviews in clinical laboratory sciences·1979
    Same journal

    Calcium measurements in serum and plasma--total and ionized.

    CRC critical reviews in clinical laboratory sciences·1979
    See all related articles

    Area of Science:

    • Immunology
    • Molecular Biology
    • Pharmacology

    Background:

    • Passive transfer of cell-mediated immunity via cell-free materials like transfer factor (TF) is increasingly understood.
    • Investigational efforts focus on identifying the specific molecules within TF responsible for its immunomodulatory effects.
    • Current research aims to elucidate the mechanisms of action of TF.

    Purpose of the Study:

    • To critically review existing and recent data on TF components and their impact on immunological and inflammatory responses.
    • To evaluate newly developed animal models for studying TF.
    • To review clinical studies assessing the efficacy of TF in various disease contexts.

    Main Methods:

    • Literature review of past and current research on transfer factor.

    Related Experiment Videos

  • Analysis of data from ongoing clinical trials.
  • Evaluation of recently developed animal models for TF research.

    • Main Results:

    • Progress in identifying TF molecules and understanding their mechanisms.
    • Ongoing clinical trials investigating TF for infections, neoplastic, and autoimmune diseases.
    • Review of animal models and clinical data to assess TF efficacy.

    Conclusions:

    • TF shows potential for treating various diseases.
    • Further research is needed to fully understand TF components and their therapeutic applications.
    • Clinical trials are crucial for validating TF's efficacy and safety.